JPRN-jRCT2062190037
Active, not recruiting
未知
Investigator-initiated trial of NIRS neurorehabilitation system for poststroke gait disturbance. - NIRS-G01
Mihara Masahito0 sites70 target enrollmentMarch 4, 2020
ConditionsStroke
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- Mihara Masahito
- Enrollment
- 70
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients aged 20 years or older with written informed consent from the patient to participate in the study
- •2\) Patients with gait disturbance due to first clinical episode of cerebral infarction or intraparenchymal hemorrhage
- •3\) Patients aged 12 weeks or more but less than 32 weeks after onset at enrollment
- •4\) Patients with a Functional Ambulation Category 3\-4 at enrollment
- •5\) Patients with a Berg Balance Scale \<\= 50 at enrollment
- •6\) Patients who can sit with feet soles on the floor for at least 10 minutes
- •7\) Patients who can be stably evaluated by the Berg balance scale and 10 m walking under the use of assistive devices such as an orthosis and a cane
- •8\) Patients who can understand verbal instructions and perform tasks adequately
Exclusion Criteria
- •1\) Patients with severe cognitive impairment, a Mini\-mental State Examination \<\= 23
- •2\) Patients with severe frontal lobe dysfunction, a Frontal Assessment Battery \<\= 12
- •3\) Patients with severe leg anesthesia, score 1, the patient recognizes movement of the digits but not the correct direction, even at maximal excursion, or less of the position sense (lower extremity) subscale in Stroke Impairment Assessment Set
- •4\) Patients with more than 90% stenosis in anterior cerebral artery on the lesion side
- •5\) Patients with cortical lesions involving the supplementary motor area
- •6\) Patients with a history of cranioplasty
- •7\) Patients with homonymous hemianopsia or severe hemispatial neglect (More than 10% deviation in a 50 cm line bisection test)
- •8\) Patients with unstable general condition including vital sign
- •9\) Patients with severe eyesight deterioration (Binocular visual acuity of 0\.05 or less with correction)
- •10\) Patients with severe infections
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical research for NIRS-EEG-BMI rehabilitation for upper limbhemiparesis patients due to stokeJPRN-UMIN000036004Keio University12
Unknown
Phase 2
NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity DisorderNCT02333422Hospital de Clinicas de Porto Alegre10
Completed
Not Applicable
The efficacy of Hypericum perforatum extract (Ze117), nicotine patches and combination Hypericum perforatum/nicotine patches for smoking cessation.ACTRN12608000500358Swinburne University of Technology60
Completed
Not Applicable
Randomized controlled trial of neurostimulation treatment for apathy in schizophreniaapathylistlessnesspsychosis10039628NL-OMON41353niversitair Medisch Centrum Groningen150
Recruiting
Not Applicable
Examination of the effect of rehabilitation using olfactory rehabilitation equipment for olfactory impaired persons after laryngectomyJPRN-UMIN000046793Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University.20